
Novartis
NVSEF | OTC
$134.20
-$6.73 (-4.78%)
At close: Oct 2, 2026, 3:14 PM ET
Novartis Statistics
Key statistics explainedMarket Data
$255.08B
$280.71B
0.49
16.65K
1.96B
-4.2%
N/A
OTC
CH0012005267
Price Performance
-14.4%
-15.2%
-13.3%
-2.8%
6.6%
40.2%
69.3%
-14.8%
10.0%
15.6%
10.1%
Valuation
19.56
13.94
-4.74
-15.08
4.62
4.20
6.08
14.13
15.01
14.14
5.09
16.80
12.36
15.56
5.1%
7.1%
6.7%
Financial Health
$23.78B
$32.64B
$7B
$104.4B
0.86
0.67
1.18
1.44
1.81
0.64
11.88
4.14
6
Margins & Profitability
74.3%
30.2%
40.2%
23.1%
32.7%
30.8%
0.5%
-5.9%
Returns
10.3%
29.6%
13.4%
18.1%
23.7%
Historical Growth (CAGR)
1.5%
2.2%
0.6%
-12.4%
16.9%
-1.5%
17.0%
7.7%
6.1%
Analyst Forecasts
Hold
0
19.9%
7.4%
Oct 27, 2026
$2.27
0.9%
$14.61B
5.1%
Fair Value Estimates
$58.38
-56.5%
$116.07
-13.5%
N/A
N/A
Cash Flow
$20.79B
$18.05B
$16.99B
$8.38
$9.49
33.0%
Income Statement
$55.19B
$42.08B
$16.68B
$22.71B
$13.71B
$6.86
$733.2K
$182.15K
75,267
Dividends
$4.74
3.53%
69.1%
42.9%
45.5%
19.2%
Annual
Mar 11, 2026
Add to Watchlist
Select watchlists to add or remove NVSEF